We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Kos Seeks Court Order to Block Launch of Generic Niaspan

Law360 (March 9, 2005, 12:00 AM EST) -- Kos Pharmaceuticals has filed a lawsuit to block Barr Pharmaceuticals from launching generic versions of Kos' cholesterol-lowering drug Niaspan upon the expiration of a 30-month stay of approval by the U.S. Food and Drug Administration.

The lawsuit, filed in U.S. District Court for the Southern District of New York, seeks a temporary restraining order and a preliminary injunction to prevent Barr from launching generic versions of Niaspan 500 mg, 750 mg and 1000 mg extended-release tablets.

The FDA has tentatively approved Barr's applications for the three...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.